Drug Repositioning
  • An oral small molecule drug approved for the treatment of microbes infections, has been changed to a new type of formulation and new route to achieve better bioavailability.
  • CAL005 can inhibit or regulate the functions of various biological signals, and has excellent inhibitory potency towards cancer cells or virus infection.
  • Applied for related patents and global layout.
Scroll to Top